BG
Bellevue Group Portfolio holdings
AUM
$4.54B
This Quarter Return
+7.64%
1 Year Return
+22.5%
3 Year Return
+98.22%
5 Year Return
+159.37%
10 Year Return
–
AUM
$6.56B
AUM Growth
+$6.56B
(+0.3%)
Cap. Flow
-$210M
Cap. Flow
% of AUM
-3.2%
Top 10 Holdings %
Top 10 Hldgs %
37.22%
Holding
183
New
22
Increased
65
Reduced
79
Closed
14
Top Buys
| 1 |
DexCom
DXCM
|
$42.5M |
| 2 |
Cooper Companies
COO
|
$31.6M |
| 3 |
SAGE
Sage Therapeutics
SAGE
|
$17.8M |
| 4 |
SI-BONE Inc
SIBN
|
$16.6M |
| 5 |
Steris
STE
|
$16.5M |
Top Sells
| 1 |
AXNX
Axonics, Inc. Common Stock
AXNX
|
$114M |
| 2 |
Intuitive Surgical
ISRG
|
$59.8M |
| 3 |
Neurocrine Biosciences
NBIX
|
$51.7M |
| 4 |
Evolent Health
EVH
|
$29.3M |
| 5 |
Vertex Pharmaceuticals
VRTX
|
$28.3M |
Sector Composition
| 1 | Healthcare | 99.12% |
| 2 | Industrials | 0.77% |
| 3 | Technology | 0.02% |
| 4 | Communication Services | 0.02% |
| 5 | Consumer Staples | 0% |
| Name | Market Value | Portfolio Weight | Shares or Principal |
Shares Change % | Capital Flow | |
|---|---|---|---|---|---|---|
76
Danaher
DHR
$147B
| $21.5M | 0.33% | 86,232 +1,922 | +2% | +$480K |
|
77
Privia Health
PRVA
$2.83B
| $20.7M | 0.32% | 1,059,171 +7,475 | +0.7% | +$146K |
|
78
HUTCHMED
HCM
$2.58B
| $19.4M | 0.3% | 1,154,632 +23,521 | +2% | +$395K |
|
|
79
SI-BONE Inc
SIBN
$719M
| $18.7M | 0.28% | 1,139,956 +1,014,756 | +811% | +$16.6M |
|
|
VRNA
80
Verona Pharma
VRNA
$9.16B
| $18.3M | 0.28% | 1,139,295 +299,299 | +36% | +$4.82M |
|
81
Pacific Biosciences
PACB
$393M
| $17.2M | 0.26% | 4,592,251 -2,724,877 | -37% | -$10.2M |
|
|
82
Steris
STE
$24.1B
| $16.5M | 0.25% | +73,434 | New | +$16.5M |
|
83
Legend Biotech
LEGN
$6.41B
| $16.4M | 0.25% | 293,270 +91,516 | +45% | +$5.13M |
|
84
Generation Bio
GBIO
$40.4M
| $15.7M | 0.24% | 3,861,575 +244,495 | +7% | +$995K |
|
85
Annexon
ANNX
$226M
| $15.6M | 0.24% | +2,182,290 | New | +$15.6M |
|
86
Structure Therapeutics
GPCR
$1.11B
| $15.6M | 0.24% | 363,926 +351,626 | +2,859% | +$15.1M |
|
87
NeoGenomics
NEO
$1.13B
| $14.9M | 0.23% | +946,025 | New | +$14.9M |
|
88
AtriCure
ATRC
$1.84B
| $13.6M | 0.21% | 447,376 -370,507 | -45% | -$11.3M |
|
89
10x Genomics
TXG
$1.74B
| $11.6M | 0.18% | 308,311 +15,138 | +5% | +$568K |
|
90
Phreesia
PHR
$1.88B
| $10.6M | 0.16% | 443,341 +21,768 | +5% | +$521K |
|
91
Omnicell
OMCL
$1.5B
| $6.88M | 0.1% | 235,372 +11,556 | +5% | +$338K |
|
92
Regeneron Pharmaceuticals
REGN
$61.5B
| $6.81M | 0.1% | 7,077 -3,632 | -34% | -$3.5M |
|
93
Amgen
AMGN
$155B
| $6.29M | 0.1% | 22,139 -12,066 | -35% | -$3.43M |
|
94
ResMed
RMD
$40.2B
| $6.02M | 0.09% | 30,391 +71 | +0.2% | +$14.1K |
|
95
Illumina
ILMN
$15.8B
| $5.99M | 0.09% | 43,596 -1,397 | -3% | -$192K |
|
96
Glaukos
GKOS
$5.5B
| $5.27M | 0.08% | +55,926 | New | +$5.27M |
|
97
AbbVie
ABBV
$372B
| $5.02M | 0.08% | 27,593 +20,866 | +310% | +$3.8M |
|
98
McKesson
MCK
$85.4B
| $4.83M | 0.07% | 8,997 +4,144 | +85% | +$2.22M |
|
99
Recursion Pharmaceuticals
RXRX
$2.04B
| $4.24M | 0.06% | 425,249 +250,692 | +144% | +$2.5M |
|
100
Teladoc Health
TDOC
$1.37B
| $4.12M | 0.06% | 272,798 +13,394 | +5% | +$202K |
|